Literature DB >> 15855312

Impact of genetic versus environmental factors on the control of muscle glycogen synthase activation in twins.

Pernille Poulsen1, Jørgen F P Wojtaszewski, Inge Petersen, Kaare Christensen, Erik A Richter, Henning Beck-Nielsen, Allan Vaag.   

Abstract

Storage of glucose as glycogen accounts for the largest proportion of muscle glucose metabolism during insulin infusion in normal and insulin-resistant subjects. Studies in first-degree relatives have indicated a genetic origin of the defective insulin activation of muscle glycogen synthase (GS) in type 2 diabetes. The aim of this study was to evaluate the relative impact of genetic versus nongenetic factors on muscle GS activation and regulation in young and elderly twins examined with a 2-h euglycemic-hyperinsulinemic (40 mU x m(-2) x min(-1)) clamp combined with indirect calorimetry and excision of muscle biopsies. The etiological components were determined using structural equation modeling. Fractional GS activity; GS phosphorylation at sites 2, 2 + 2a, and 3a + 3b corrected for total GS protein; and GS kinase 3 (GSK3) activity were similar in both age groups, whereas total GS activity and protein were lower in elderly compared with younger twins. GS fractional activity increased significantly during insulin stimulation in both young and elderly twins. Conversely, there was a significant decrease in GS phosphorylation at site 3a + 3b and GSK3 activity during insulin stimulation in both age groups, whereas GS phosphorylation at site 2 and 2 + 2a only decreased on insulin stimulation in the younger twins. The increment in whole-body glucose disposal (Rd) and nonoxidative glucose metabolism (insulin - basal) correlated significantly with the increment in GS fractional activity. Fractional GS activity had a major environmental component in both age groups. GSK3 activity exhibited a genetic component in young (basal: a2 = 0.42; insulin: a2 = 0.58) and elderly (insulin: a2 = 0.56) twins. Furthermore, GS phosphorylation at site 2 (insulin: a2 = 0.69) in the elderly and at site 3a + 3b (insulin: a2 = 0.50) in the young twins had a genetic component. In conclusion, GSK3 activity and GS phosphorylation, particularly at sites 2 and 3a + 3b, had major genetic components. Total and fractional GS activities per se were, on the other hand, predominantly controlled by environmental factors. Moreover, GS activity was intact with increasing age, despite a significant reduction in nonoxidative glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855312     DOI: 10.2337/diabetes.54.5.1289

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  9 in total

1.  Dysregulation of muscle glycogen synthase in recovery from exercise in type 2 diabetes.

Authors:  Andreas J T Pedersen; Janne R Hingst; Martin Friedrichsen; Jonas M Kristensen; Kurt Højlund; Jørgen F P Wojtaszewski
Journal:  Diabetologia       Date:  2015-04-14       Impact factor: 10.122

2.  Partial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene.

Authors:  K Højlund; J F P Wojtaszewski; J Birk; B F Hansen; H Vestergaard; H Beck-Nielsen
Journal:  Diabetologia       Date:  2006-06-08       Impact factor: 10.122

3.  Differential aetiology and impact of phosphoinositide 3-kinase (PI3K) and Akt signalling in skeletal muscle on in vivo insulin action.

Authors:  M Friedrichsen; P Poulsen; E A Richter; B F Hansen; J B Birk; R Ribel-Madsen; K Stender-Petersen; E Nilsson; H Beck-Nielsen; A Vaag; J F P Wojtaszewski
Journal:  Diabetologia       Date:  2010-05-29       Impact factor: 10.122

4.  Hyperglycaemia normalises insulin action on glucose metabolism but not the impaired activation of AKT and glycogen synthase in the skeletal muscle of patients with type 2 diabetes.

Authors:  B F Vind; J B Birk; S G Vienberg; B Andersen; H Beck-Nielsen; J F P Wojtaszewski; K Højlund
Journal:  Diabetologia       Date:  2012-02-10       Impact factor: 10.122

5.  Akt2 influences glycogen synthase activity in human skeletal muscle through regulation of NH₂-terminal (sites 2 + 2a) phosphorylation.

Authors:  Martin Friedrichsen; Jesper B Birk; Erik A Richter; Rasmus Ribel-Madsen; Christian Pehmøller; Bo Falck Hansen; Henning Beck-Nielsen; Michael F Hirshman; Laurie J Goodyear; Allan Vaag; Pernille Poulsen; Jørgen F P Wojtaszewski
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

6.  Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia.

Authors:  Johan Rung; Stéphane Cauchi; Anders Albrechtsen; Lishuang Shen; Ghislain Rocheleau; Christine Cavalcanti-Proença; François Bacot; Beverley Balkau; Alexandre Belisle; Knut Borch-Johnsen; Guillaume Charpentier; Christian Dina; Emmanuelle Durand; Paul Elliott; Samy Hadjadj; Marjo-Riitta Järvelin; Jaana Laitinen; Torsten Lauritzen; Michel Marre; Alexander Mazur; David Meyre; Alexandre Montpetit; Charlotta Pisinger; Barry Posner; Pernille Poulsen; Anneli Pouta; Marc Prentki; Rasmus Ribel-Madsen; Aimo Ruokonen; Anelli Sandbaek; David Serre; Jean Tichet; Martine Vaxillaire; Jørgen F P Wojtaszewski; Allan Vaag; Torben Hansen; Constantin Polychronakos; Oluf Pedersen; Philippe Froguel; Robert Sladek
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

Review 7.  Impact of Endurance and Resistance Training on Skeletal Muscle Glucose Metabolism in Older Adults.

Authors:  Leslie A Consitt; Courtney Dudley; Gunjan Saxena
Journal:  Nutrients       Date:  2019-11-03       Impact factor: 5.717

8.  Impact of rs361072 in the phosphoinositide 3-kinase p110beta gene on whole-body glucose metabolism and subunit protein expression in skeletal muscle.

Authors:  Rasmus Ribel-Madsen; Pernille Poulsen; Johan Holmkvist; Brynjulf Mortensen; Niels Grarup; Martin Friedrichsen; Torben Jørgensen; Torsten Lauritzen; Jørgen F P Wojtaszewski; Oluf Pedersen; Torben Hansen; Allan Vaag
Journal:  Diabetes       Date:  2010-01-27       Impact factor: 9.461

9.  Prostaglandin EP3 receptor signaling is required to prevent insulin hypersecretion and metabolic dysfunction in a non-obese mouse model of insulin resistance.

Authors:  Jaclyn A Wisinski; Austin Reuter; Darby C Peter; Michael D Schaid; Rachel J Fenske; Michelle E Kimple
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-07-06       Impact factor: 4.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.